Index your Journal on RJRIndex — A product by ResearchJournalRank.com Index Now
34,970+ Journals Indexed Journal Suggester  |  Paper Finder  |  Compare Journals
Home › Molecular Therapy Nucleic Acids

Molecular Therapy Nucleic Acids

Q1 Journal Open Access Scopus Active Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└ Drug Discovery Q1
└ Molecular Medicine Q1
Publisher
SJR 2025
2.068
Q1
SJR Score
H-Index
113
Citations / Doc (2yr)
5.38
Total Docs. (latest)
348
Total Citations (3yr)
4,762
Publication type
Journals
ISSN
21622531
Coverage
2012-2026
Journal Rank
#1,346
Advertisement

Subject Categories

Drug Discovery Q1
Molecular Medicine Q1

Aims & Scope

Molecular Therapy — Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials. Other key topics include: Applications of DNA-based oligonucleotides and their derivatives Gene vectors for delivery of RNA-based therapies Development of nanoparticles and other delivery agents siRNAs, shRNAs, and miRNAs Aptamers, ribozymes, and DNAzymes Peptide nucleic acids Gene-modifying approaches including enzymes, triplex-forming nucleic acids, and other approaches Development of new nucleic acid chemistries for altering gene expression Mechanisms of gene and nucleic acid transfer/transfection Vector trafficking and biodistribution.

Abstracting & Indexing

Scopus Google Scholar Directory of Open Access Journals (DOAJ) Web of Science Embase

Detailed Metrics

Total Docs. (latest) 348
Total Docs. (3 years) 852
Total Refs. 21,803
Total Citations (3 years) 4,762
Citable Docs. (3 years) 712
Citations / Doc. (2 years) 5.38
Ref. / Doc. 62.65
% Female 45.2%

Metrics Visualization

Latest year data vs 3-year cumulative figures

Publication & Citation Trend

Loading trend data from Crossref...

Top 10 Most Cited Articles

Loading articles...

Frequently Asked Questions

What is the impact factor of Molecular Therapy Nucleic Acids?

The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Molecular Therapy Nucleic Acids has an SJR of 2.068 and is ranked Q1.

What is the SJR and quartile of Molecular Therapy Nucleic Acids?

Molecular Therapy Nucleic Acids has an SJR (SCImago Journal Rank) of 2.068 and its best quartile is Q1.

What is the H-index of Molecular Therapy Nucleic Acids?

The H-index of Molecular Therapy Nucleic Acids is 113, meaning 113 of its articles have each been cited at least 113 times.

Is Molecular Therapy Nucleic Acids indexed in Scopus?

Yes. Molecular Therapy Nucleic Acids is active in Scopus (Scopus Source List, August 2026).

Advertisement

Journal Information

SJR2.068
Best QuartileQ1
H Index113
ISSN21622531
PublisherCell Press
CountryUnited States
RegionNorthern America
Coverage2012-2026
Open AccessYes
TypeJournal
Rank#1,346

Similar Journals

View all Biochemistry, Genetics and Molecular Biology journals

Embed This Journal

Add this journal's ranking badge to your website:

<iframe src="https://researchjournalrank.com/widget.php?id=1376" style="border:1px solid #e0e0e0;border-radius:8px;width:100%;max-width:320px;height:200px" frameborder="0"></iframe>
Preview:

Researcher Reviews

Write a Review

No reviews yet for this journal.

Be the first to share your experience!

Share Your Experience

Your review will be published after moderation. Email will not be displayed publicly.

★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★